The compounding benefits of effective training cannot be overstated. When clinical research associates (CRAs) and site staff are thoroughly prepared, they engage more deeply with the trial protocols, ask more insightful questions, and more proactively anticipate challenges.
2021 was a historic year in the battle to defeat cancer. More novel cancer treatments became available than ever before with the number of Oncology
It should come as little surprise that the rise in decentralized trials (DCTs) and increase in study complexities have magnified performance demands across clinical trial
How can you minimize the performance risks given the complexities of a clinical trial and be ready to effectively conduct your next study?
Atul Mahableshwarkar, M.D., DFAPA, joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss clinical trial methodology. A self-described “trial nerd,”
The area of clinical research known as CNS (central nervous system conditions) is commonly cited for its complexity and the subjective nature of many assessment
Jennifer Brandl joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss the feasibility and pros and cons of virtual site
Watch on Demand Now! Clinical trials are more complex than ever. And 85% of them are delayed. More screening criteria, more procedures, new vendor systems
It’s impossible to read an industry publication without hearing about virtual clinical trials, decentralized clinical trials, or hybrid trials. Industry leaders and technology companies are
Updated 16 November 2021. The clinical operations conference landscape was nothing if not fluid in 2021, so you may be wondering what events focused on
Peju Oshisanya joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss diversity and inclusion in clinical trials. An experienced clinical
If it shocks you to hear that clinical trials are getting more complex, you haven’t been paying attention. Specifically, we’re collecting more endpoints. We’re performing
By all accounts, the cost of clinical trials continues to rise. We hear reasons that include increasing protocol complexity, patient recruitment struggles, or regulatory challenges.
ArcheMedX helps life sciences and healthcare organizations to better equip, evaluate, and predict team and clinician performance
